Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 5, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity. Key metrics from the transaction include:
- Shares Purchased: 465,000 ordinary shares
- Purpose: Cancellation under the Buyback Programme
- Highest Price Paid: 388.90 pence per share
- Lowest Price Paid: 385.00 pence per share
- Volume Weighted Average Price: 386.6139 pence per share
- Post-Transaction Share Capital: 9,122,352,072 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of 465,000 shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It serves as a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation (Article 5s(1)(b)).
Investor Verification Checklist
- Verify the total number of shares purchased to date under the August 1, 2024 Buyback Programme.
- Confirm the updated total registered share capital of 9,122,352,072 shares for disclosure threshold calculations.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check the company website (www.haleon.com/investors) for further updates on the buyback programme status.